Express Scripts (NASDAQ:ESRX) Rating Kept
In a research report sent to investors and clients on Thursday morning, Express Scripts (NASDAQ:ESRX) stock “Buy” was reiterated by Maxim Group. They currently have a $87.0 target on the stock. Maxim Group’s target gives a potential upside of 41.95 % from the company’s close price.
NASDAQ:ESRX is right now trading -0.02% lower at $61.55 as of 6:04 PM New York time. Express Scripts’s stock is 0% over the last 200 days. It has underperformed the S&P 500 Index, which has gained 6.00% over the same time period.
Out of 18 analysts covering Express Scripts, 0 rate it a Buy, 0 indicate a Hold while 0 suggest a Sell. The highest target is $95 and the lowest is $63 according to Thomson/First Call. The 12-month mean target is $80.33, which means upside potential of 30.51% over the current price.
Green Valley Investors Llc had the largest stake with ownership of 5.12 million shares as of q2 2015 for 18.5% of the US long equity exposure. Chieftain Capital Management Inc. is another bullish active investment manager who is having 4.14 million shares of Express Scripts or 16.84% of their US long equity exposure. Moreover, Bloombergsen Inc. have 11.48% of their US long equity exposure invested in the company for 1.67 million shares. The Missouri-based fund Cortland Associates Inc Mo disclosed it had purchased so far a stake worth about 10.97% of the active investment manager’s stock portfolio in Express Scripts. The New York-based fund Capital Counsel Llc Ny is also positive about the stock, possessing 766,479 shares or 9.77% of their US long equity exposure.
Express Scripts (NASDAQ:ESRX) traded down -0.02% on 14 December, hitting $61.55. A total of 2.16M shares of the company’s stock traded hands. This is down from average of 4.01M shares. Express Scripts has a 52 week low of $57.80 and a 52 week high of $80.02. The company has a market cap of $36.70B and a P/E ratio of 11.23.
Get the latest Express Scripts (NASDAQ:ESRX) Stock Ratings at Octafinance. Completely free access to our Analyst Ratings Database for 6000+ stocks.
The post Express Scripts (NASDAQ:ESRX) Investors: Maxim Group Reaffirms “Buy” Rating, Sees $87.0/Share appeared first on Octafinance.